Your browser doesn't support javascript.
loading
Contribution of induced pluripotent stem cell technologies to the understanding of cellular phenotypes in schizophrenia.
Balan, Shabeesh; Toyoshima, Manabu; Yoshikawa, Takeo.
Affiliation
  • Balan S; Laboratory for Molecular Psychiatry, RIKEN Center for Brain Science (formerly RIKEN Brain Science Institute), Saitama 351-0198, Japan.
  • Toyoshima M; Laboratory for Molecular Psychiatry, RIKEN Center for Brain Science (formerly RIKEN Brain Science Institute), Saitama 351-0198, Japan.
  • Yoshikawa T; Laboratory for Molecular Psychiatry, RIKEN Center for Brain Science (formerly RIKEN Brain Science Institute), Saitama 351-0198, Japan. Electronic address: takeo.yoshikawa@riken.jp.
Neurobiol Dis ; 131: 104162, 2019 11.
Article in En | MEDLINE | ID: mdl-29729395
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia / Induced Pluripotent Stem Cells / Neurons Type of study: Prognostic_studies Limits: Humans Language: En Journal: Neurobiol Dis Journal subject: NEUROLOGIA Year: 2019 Document type: Article Affiliation country: Japan Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia / Induced Pluripotent Stem Cells / Neurons Type of study: Prognostic_studies Limits: Humans Language: En Journal: Neurobiol Dis Journal subject: NEUROLOGIA Year: 2019 Document type: Article Affiliation country: Japan Country of publication: United States